SYNERGISTIC COMBINATIONS OF LATENCY-REVERSING AGENTS IDENTIFIED USING CRISPR SCREENS
HIV-1 persisting in a latent form in resting CD4+ T cells despite effective antiretroviral therapy is the major barrier to cure. A promising therapeutic approach known as ‘shock and kill’ seeks to achieve cure by sequentially reversing latency in infected cells and then promoting the killing of productively infected cells. To date, however, no single…